3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
12
Carcinoma, Medullary
9
Lung Neoplasms
8
Thyroid Neoplasms
7
Neoplasms
5
Neoplasm Metastasis
5
Squamous Cell Carcinoma of Head and Neck
3
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Carcinoma, Renal Cell
3
Breast Neoplasms
3
Stomach Neoplasms
2
Pleural Effusion
2
Kidney Neoplasms
2
Gliosarcoma
2
Glioblastoma
2
Familial medullary thyroid carcinoma
2
Fallopian Tube Neoplasms
2
Urinary Bladder Neoplasms
1
Thyroid cancer, medullary
1
Thyroid Diseases
1
Thyroid Cancer, Papillary
1
Small Cell Lung Carcinoma
1
Recurrence
1
Rectal Neoplasms
1
Precancerous Conditions
1
Peritoneal Neoplasms
1
Oligodendroglioma
1
Multiple Endocrine Neoplasia Type 2b
1
Multiple Endocrine Neoplasia Type 2a
1
Interventions
Cyclophosphamide
21
fludarabine phosphate
18
Whole-Body Irradiation
17
Methotrexate
17
Tacrolimus
15
Peripheral Blood Stem Cell Transplantation
15
Mycophenolic Acid
13
Dexamethasone
11
Vincristine
10
Etoposide
10
Antilymphocyte Serum
10
Calcium Dobesilate
9
Busulfan
9
Rituximab
8
Doxorubicin
8
merphos
7
Filgrastim
7
Cytarabine
7
Sirolimus
6
Prednisone
6
Melphalan
6
Granulocyte Colony-Stimulating Factor
6
Cyclosporine
6
pegaspargase
5
dexamethasone acetate
5
dexamethasone 21-phosphate
5
prednylidene
4
deltacortene
4
auricularum
4
Radiotherapy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
×
vandetanib
×
Clear all
No trials found.